CBD and Depression: Evidence, Risks, and Treatment Options

CBD is not an established treatment for depression or a proven replacement for antidepressants or psychotherapy. Laboratory findings and personal reports have generated interest, but they do not establish an effective dose, lasting benefit, or safety for people with depressive disorders.

What CBD Is—and What Its Approval Means

Cannabidiol, or CBD, is a cannabinoid found in cannabis. It does not produce the same intoxication as THC. That distinction does not mean it is harmless, reliably relaxing, or effective for every condition for which it is marketed.

The FDA has approved prescription CBD for specific seizure disorders. That approval does not establish benefit for depression or make consumer CBD oils and gummies equivalent to the prescription medicine. Retail availability also does not establish that a product’s medical claims have been evaluated.

What the Human Evidence Shows

A 2026 systematic review of 54 randomized cannabinoid trials involving 2,477 participants found no randomized trial evidence for treating depression within the literature it included. Its search covered publications through May 2025, and most outcome evidence across the conditions studied was low certainty. This is an evidence gap, not proof that CBD is an effective antidepressant.

The often-cited 2018 study by Cuttler and colleagues examined app-based reports from cannabis users. It found short-term perceived reductions in depression, anxiety, and stress, but not evidence of lasting symptom reductions with repeated use. Participants were not randomized to CBD or placebo, and the products also contained THC.

That study cannot establish a recommended CBD percentage, THC percentage, or product for depression. Nor can a rat experiment or an individual case report show that CBD will produce remission in people with major depressive disorder. A biological effect involving serotonin signaling is not evidence that CBD works like an SSRI in clinical care.

New Trials Are Questions, Not Answers

A Brazilian trial registered in March 2026 describes a planned comparison of full-spectrum CBD oil and placebo in 60 adults with treatment-resistant major depression over 12 weeks. Participants are to continue stable prescribed antidepressants. The registry describes planned outcomes rather than published treatment results.

Trials like this may help clarify whether a specific preparation offers additional benefit. Until results are available and critically assessed, registration itself should not be presented as evidence that CBD treats depression. An add-on trial also cannot establish that stopping antidepressants and switching to CBD is effective.

CBD Can Interact With Antidepressants

In a 2026 clinical interaction study, a cohort of 20 healthy adults received citalopram with and without repeated CBD dosing. At 2.5 mg/kg CBD twice daily, citalopram’s overall exposure increased by about 43%, and its peak concentration increased by about 12%. This was an interaction study, not a depression-treatment trial.

The result does not predict the exact effect of every consumer product or every antidepressant. It does show why adding CBD requires a medication review. Tell the prescriber or pharmacist the product, milligram amount, frequency, and any THC or other ingredients. Do not change antidepressant doses yourself to compensate for a suspected interaction.

CBD can also cause liver injury and drowsiness. Combining it with alcohol or other sedating substances can increase impairment. A label such as “natural” or “non-intoxicating” does not remove these risks. See the FDA’s safety information above and discuss any new symptoms with a clinician.

Use Treatments With Evidence for Depression

NIMH describes psychotherapy, medication, or their combination as standard depression treatments. The choice depends on symptom severity, preferences, medical history, and prior response. If initial treatment is not helping enough, a clinician can reassess the diagnosis and discuss adjustments or other options.

Do not abruptly stop a prescribed antidepressant to try CBD. A clinical review can help distinguish persistent depression, medication side effects, sleep problems, substance effects, and other contributors. There is no established consumer CBD dose or strain for treating depression.

If you are in emotional crisis or having suicidal thoughts in the United States, call or text 988 for support. If there is immediate danger or a medical emergency, call 911. CBD is not a substitute for urgent care.